Prognostic Factors in Radiation-Treated Esophageal Carcinoma

Authors

  • Shogo Yamada Department of Radiology, Tohoku University, School of Medicine, Sendai, Japan
  • Yoshihiro Takai Department of Radiology, Tohoku University, School of Medicine, Sendai, Japan
  • Kenji Nemoto Department of Radiology, Tohoku University, School of Medicine, Sendai, Japan
  • Yoshihiro Ogawa Department of Radiology, Tohoku University, School of Medicine, Sendai, Japan
  • Yoshihisa Kakuto Department of Radiology, Tohoku University, School of Medicine, Sendai, Japan
  • Akihiko Hoshi Department of Radiology, Tohoku University, School of Medicine, Sendai, Japan
  • Kiyohiko Sakamoto Department of Radiology, Tohoku University, School of Medicine, Sendai, Japan

DOI:

https://doi.org/10.3109/02841869209088307

Abstract

Prognostic factors in esophageal carcinoma treated with irradiation were examined. The prognosis of 111 patients without metastasis who had received more than 60 Cy was analyzed. Significant associations were found between survival rates and tumor length, stage, Radioresponse of the primary tumor and the S.C. X-P classification based on barium contrast radiography; superficial type (tumor limited to the surface of the esophageal wall), tumourous type (solid mass without ulceration), UI-A type (tumor with shallow ulceration with regular margin), UI-B type (tumor with deep ulceration or irregular ulcer margin), and funneled type (tumor invading the esophageal wall in a scirrhous pattern). In multiple regression analysis, the X-P classification had the strongest correlation with survival and the survival rates of patients with the superficial type, the tumourous type and the S.C. UI-A type were significantly higher than those of patients with the other tumor types (p < 0.001).

Downloads

Download data is not yet available.

Downloads

Published

1992-01-01

How to Cite

Yamada, S., Takai, Y., Nemoto, K., Ogawa, Y., Kakuto, Y., Hoshi, A., & Sakamoto, K. (1992). Prognostic Factors in Radiation-Treated Esophageal Carcinoma. Acta Oncologica, 31(5), 563–567. https://doi.org/10.3109/02841869209088307